Modified Vaccinia Ankara – Bavarian Nordic Live Virus

3 trials 2 recruiting JAnti-infectives

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

2 Recruiting

1 Completed trials

3 Sponsors

5 Countries

Phase III

Phase II/III

Phase IV

Phase III: 1 Phase II/III: 1 Phase IV: 1

Oversight events:

1 serious breach across 1 trial

View oversight register →

Sponsors using this IMP

Academisch Ziekenhuis Leiden 1 The Public Health Agency Of Sweden 1 University College Dublin 1

All trials

3 total

A Phase III Randomised, Open Label Trial of an Intradermal or Subcutaneous booster dose of MVA-BN Vaccine to Investigate MPXV Immunogenicity… Recruiting

2024-518007-22-00 Phase III 4 countries The Public Health Agency Of Sweden
The effect of a booster vaccination on protection against the mpox virus: is a booster vaccination with a lower dose as effective as the sta… Recruiting

2024-510697-24-00 Phase II/III 1 country Academisch Ziekenhuis Leiden
Vaccination to prevent Mpox Infection (MPOX-VAX Study) Ended

2023-507881-19-00 Phase IV 1 country University College Dublin

Showing 1–3 of 3 trials

← All drugs A–Z